- Report
- October 2024
- 125 Pages
Asia Pacific
From €3046EUR$3,450USD£2,641GBP
- Report
- April 2025
- 85 Pages
United States
From €3090EUR$3,500USD£2,679GBP
- Report
- July 2025
- 162 Pages
Latin America
From €3178EUR$3,599USD£2,755GBP
- Report
- May 2025
- 145 Pages
United States
From €2207EUR$2,500USD£1,913GBP
- Report
- February 2025
- 61 Pages
North America
From €5293EUR$5,995USD£4,588GBP
- Report
- February 2025
- 84 Pages
Europe
From €5293EUR$5,995USD£4,588GBP
- Report
- February 2025
- 81 Pages
Asia Pacific
From €5293EUR$5,995USD£4,588GBP
- Report
- February 2025
- 33 Pages
United States
From €4410EUR$4,995USD£3,823GBP
- Report
- March 2025
- 82 Pages
Africa, Middle East
From €2605EUR$2,950USD£2,258GBP
- Report
- March 2025
- 96 Pages
Asia Pacific
From €3046EUR$3,450USD£2,641GBP
- Report
- March 2025
- 99 Pages
Europe
From €3046EUR$3,450USD£2,641GBP
- Report
- March 2025
- 88 Pages
North America
From €2605EUR$2,950USD£2,258GBP
- Report
- August 2023
- 477 Pages
Global
From €4716EUR$5,529USD£3,950GBP
- Report
- November 2023
- 241 Pages
Global
From €1757EUR$1,990USD£1,523GBP
- Report
- February 2022
- 277 Pages
Global
From €1934EUR$2,190USD£1,676GBP
- Report
- March 2024
- 278 Pages
Global
From €4371EUR$4,950USD£3,789GBP
- Report
- January 2024
- 459 Pages
Global
From €6313EUR$7,150USD£5,472GBP
- Report
- March 2023
- 281 Pages
Global
From €2967EUR$3,360USD£2,572GBP
€3708EUR$4,200USD£3,215GBP
- Report
- February 2023
- 282 Pages
Global
From €2967EUR$3,360USD£2,572GBP
€3708EUR$4,200USD£3,215GBP
- Report
- June 2022
- 264 Pages
Global
From €2472EUR$2,800USD£2,143GBP
€3090EUR$3,500USD£2,679GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more